Replies to post #120698 on Elite Pharmaceuticals Inc (ELTP)

[DR Ryan]

Nice find Hike, could be a big # indeed next Q.

Nasrat Hakim, CEO of Elite commented, "We had a solid start to our fiscal year. Our generic product lines are performing well and our pipeline of new generic products being transferred will provide further opportunities for growth. The development of our abuse-deterrent opioid products continues to progress at a rapid pace. We are on schedule to file our first product this year. In addition, Elite’s balance sheet is stronger and we cured the monetary bond default, all of which provides stability for our future.”